Arborsense

Materials Science & Nanotechnology · Advanced Materials
Sponsors visas

Facts

as of Nov 17, 2026

Arborsense is commercializing its patented graphene-based sensor technology for rapid and sensitive monitoring of biochemical markers.

Headquarters
Ann Arbor, United States
Employees
11-50estimated range
Website
arborsense.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Named in the work visa registers of United States.

0H-1B filings in 12 months
0Open roles in United States

In the register as Arborsense Inc., Ann Arbor, MI

Other sponsors in the same field
Alert me
US Department of Labor · latest filing Apr 23, 2025

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Ann Arbor United StatesHeadquarters0
Source: office addresses in postings and company registers

Financials

5 public grants on record, $3.3M in total.

$3.3MPublic grants5 public grants
Money by yearUSD, rounds and grants
2022$1.7M1 record
2020$1.3M2 records
2017$145k1 record
2016$150k1 record
Largest rounds and grants
2022
$1.7M
2020
$985k
2020
$307k
2016
$150k
2017
$145k
Sources: funding announcements, grant and company registers

Milestones

Aug 1, 2022
Won a grant $1.7M · CORDIS
Sep 30, 2020
Won a grant $307k · CORDIS
Each milestone is dated by its source: registers, filings, the press

Newsroom

Nov 25, 20252025
News · The Michigan Daily
Arborsense, an Ann Arbor-based health technology startup, has developed wrist-worn wearable devices that detect chemicals in human sweat in order to assist in 24/7 alcohol monito…
Sources: the outlets named on each headline, each story once